FDA clears Siemens' 2-in-1 medical scanner

Jun 10, 2011

(AP) -- The Food and Drug Administration says it has cleared the first medical imaging device to simultaneously perform two powerful scans used to diagnose a wide variety of diseases and ailments.

The agency says Siemens' Biograph mMR system runs both a positron emission tomography scan, known as a PET scan, and a scan, or MRI scan. The combination is expected to save time and reduce patients' exposure to radiation.

Older devices combine a and computer tomography, which uses high-powered X-ray scans. Siemens' device replaces that technology with the MRI, which does not contain radiation.

MRI scans use magnetic fields to produce detailed images of organs, bones and other internal structures. PET scans work with a radioactive injection to trace blood flow throughout the body.

Explore further: FDA warns of compounded drug recall by Texas firm

not rated yet
add to favorites email to friend print save as pdf

Related Stories

MRI/PET scanner combo

Mar 07, 2008

Two kinds of body imaging -- positron emission tomography (PET) and magnetic resonance imaging (MRI) -- have been combined for the first time in a single scanner.

New scans improve treatment accuracy

Sep 14, 2006

Australian doctors say they have developed new scans that can that quickly show whether breast cancer cells are responding to therapy.

Recommended for you

EU regulator: Morning-after pill OK for all women

30 minutes ago

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

4 hours ago

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

Zydelig approved for three types of blood cancer

5 hours ago

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Journal raises concern about blood-thinning drug

18 hours ago

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

User comments : 0